Literature DB >> 34337902

Differential responses in EPA and fucoxanthin production by the marine diatom Stauroneis sp. under varying cultivation conditions.

Rachel Parkes1, Lorraine Archer2, Dónal Mc Gee3, Thomas J Smyth4, Eoin Gillespie1, Nicolas Touzet1.   

Abstract

There has been an increasing drive toward better valorising raw biological materials in the context of the sustainability of bio-based industries and the circular economy. As such, microalgae hold the ability to biosynthesise valuable metabolites, which are sought after within the bioenergy, pharmaceuticals, cosmetics or nutrition sectors. Owing to their bioactivities, the xanthophyll pigment fucoxanthin and the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) have fostered increasing interests in terms of sustainably refining them from natural sources, such as microalgae. Together with the suitability of individual species to industrial cultivation, a key challenge resides in optimizing the yields of these compounds within the microalgal biomass they are retrieved from. The marine diatom Stauroneis sp. LACW24 was batch cultivated into its stationary phase of growth prior to being subjected at high cell density (1 × 106  cells mL-1 ) to seven different regimes of light exposure in replenished medium and under nutritional limitation (silica and nitrate) for 12 days. The highest EPA proportions and yields were obtained under blue LED in f/2 medium (16.5% and 4.8 mg g-1 , respectively), double the values obtained under red LED illumination. The fucoxanthin yield was the highest when cells were subjected to blue LEDs (5.9 mg g-1 ), a fourfold increase compared to the nitrogen-limited treatment under white LEDs. These results indicate that a two-stage approach to the batch cultivation of this diatom can be used for enhancing the production of the high-value metabolites fucoxanthin and EPA post-stationary phase.
© 2021 American Institute of Chemical Engineers.

Entities:  

Keywords:  EPA; LEDs; diatom; fucoxanthin; marine; microalgae

Mesh:

Substances:

Year:  2021        PMID: 34337902     DOI: 10.1002/btpr.3197

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  6 in total

1.  Influence of exogenous phytohormone supplementation on the pigment and fatty acid content of three marine diatoms.

Authors:  David Fierli; Anita Aranyos; Maria Elena Barone; Rachel Parkes; Nicolas Touzet
Journal:  Appl Microbiol Biotechnol       Date:  2022-08-30       Impact factor: 5.560

2.  Antioxidant Activity and Carotenoid Content Responses of Three Haematococcus sp. (Chlorophyta) Strains Exposed to Multiple Stressors.

Authors:  Rachel Parkes; Maria Elena Barone; Helen Herbert; Eoin Gillespie; Nicolas Touzet
Journal:  Appl Biochem Biotechnol       Date:  2022-04-25       Impact factor: 3.094

Review 3.  Recent Progress on Systems and Synthetic Biology of Diatoms for Improving Algal Productivity.

Authors:  Jiwei Chen; Yifan Huang; Yuexuan Shu; Xiaoyue Hu; Di Wu; Hangjin Jiang; Kui Wang; Weihua Liu; Weiqi Fu
Journal:  Front Bioeng Biotechnol       Date:  2022-05-13

Review 4.  Fucoxanthin from Algae to Human, an Extraordinary Bioresource: Insights and Advances in up and Downstream Processes.

Authors:  Anne Pajot; Gia Hao Huynh; Laurent Picot; Luc Marchal; Elodie Nicolau
Journal:  Mar Drugs       Date:  2022-03-23       Impact factor: 6.085

Review 5.  Application of Microalgal Stress Responses in Industrial Microalgal Production Systems.

Authors:  Jia Wang; Yuxin Wang; Yijian Wu; Yuwei Fan; Changliang Zhu; Xiaodan Fu; Yawen Chu; Feng Chen; Han Sun; Haijin Mou
Journal:  Mar Drugs       Date:  2021-12-26       Impact factor: 5.118

6.  Total Phenolic Levels, In Vitro Antioxidant Properties, and Fatty Acid Profile of Two Microalgae, Tetraselmis marina Strain IMA043 and Naviculoid Diatom Strain IMA053, Isolated from the North Adriatic Sea.

Authors:  Riccardo Trentin; Luísa Custódio; Maria João Rodrigues; Emanuela Moschin; Katia Sciuto; José Paulo da Silva; Isabella Moro
Journal:  Mar Drugs       Date:  2022-03-12       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.